Literature DB >> 24980190

Targeting notch in prostate cancer--combination is the key.

Laure Marignol1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24980190     DOI： 10.1038/nrurol.2013.110-c3

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  15 in total

1.  Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice.

Authors:  Mitomu Kioi; Hannes Vogel; Geoffrey Schultz; Robert M Hoffman; Griffith R Harsh; J Martin Brown
Journal:  J Clin Invest       Date:  2010-02-22       Impact factor: 14.808

2.  Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells.

Authors:  Johan H van Es; Marielle E van Gijn; Orbicia Riccio; Maaike van den Born; Marc Vooijs; Harry Begthel; Miranda Cozijnsen; Sylvie Robine; Doug J Winton; Freddy Radtke; Hans Clevers
Journal:  Nature       Date:  2005-06-16       Impact factor: 49.962

Review 3.  Notch signaling, gamma-secretase inhibitors, and cancer therapy.

Authors:  Ie-Ming Shih; Tian-Li Wang
Journal:  Cancer Res       Date:  2007-03-01       Impact factor: 12.701

Review 4.  Hypoxia, notch signalling, and prostate cancer.

Authors:  Laure Marignol; Karla Rivera-Figueroa; Thomas Lynch; Donal Hollywood
Journal:  Nat Rev Urol       Date:  2013-05-28       Impact factor: 14.432

Review 5.  Signaling epigenetics: novel insights on cell signaling and epigenetic regulation.

Authors:  Rodrigo G Arzate-Mejía; David Valle-García; Félix Recillas-Targa
Journal:  IUBMB Life       Date:  2011-09-07       Impact factor: 3.885

6.  A recipe for targeted therapy in prostate cancer.

Authors:  Shigeo Masuda; Juan Carlos Izpisua Belmonte
Journal:  Nat Rev Urol       Date:  2014-07-01       Impact factor: 14.432

7.  Notch-3 and Notch-4 signaling rescue from apoptosis human B-ALL cells in contact with human bone marrow-derived mesenchymal stromal cells.

Authors:  Armel Hervé Nwabo Kamdje; Federico Mosna; Francesco Bifari; Veronica Lisi; Giulio Bassi; Giorgio Malpeli; Mario Ricciardi; Omar Perbellini; Maria Teresa Scupoli; Giovanni Pizzolo; Mauro Krampera
Journal:  Blood       Date:  2011-05-20       Impact factor: 22.113

8.  Randomized, double-blind, placebo-controlled phase III trial comparing docetaxel and prednisone with or without bevacizumab in men with metastatic castration-resistant prostate cancer: CALGB 90401.

Authors:  William Kevin Kelly; Susan Halabi; Michael Carducci; Daniel George; John F Mahoney; Walter M Stadler; Michael Morris; Philip Kantoff; J Paul Monk; Ellen Kaplan; Nicholas J Vogelzang; Eric J Small
Journal:  J Clin Oncol       Date:  2012-03-26       Impact factor: 44.544

9.  Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial.

Authors:  Ian F Tannock; Karim Fizazi; Sergey Ivanov; Camilla Thellenberg Karlsson; Aude Fléchon; Iwona Skoneczna; Francisco Orlandi; Gwenaelle Gravis; Vsevolod Matveev; Sevil Bavbek; Thierry Gil; Luciano Viana; Osvaldo Arén; Oleg Karyakin; Tony Elliott; Alison Birtle; Emmanuelle Magherini; Laurence Hatteville; Daniel Petrylak; Bertrand Tombal; Mark Rosenthal
Journal:  Lancet Oncol       Date:  2013-06-04       Impact factor: 41.316

10.  Inhibition of angiogenesis and tumor growth by beta and gamma-secretase inhibitors.

Authors:  Daniel Paris; Amita Quadros; Nikunj Patel; Anthony DelleDonne; James Humphrey; Michael Mullan
Journal:  Eur J Pharmacol       Date:  2005-05-02       Impact factor: 4.432
View more
  4 in total

1.  Targeting Notch Signaling in Colorectal Cancer.

Authors:  Suman Suman; Trinath P Das; Murali K Ankem; Chendil Damodaran
Journal:  Curr Colorectal Cancer Rep       Date:  2014-12-01

2.  Targeted inhibition of SIRT6 via engineered exosomes impairs tumorigenesis and metastasis in prostate cancer.

Authors:  Qing Han; Qian Rueben Xie; Fan Li; Yirui Cheng; Tingyu Wu; Yanshuang Zhang; Xin Lu; Alice S T Wong; Jianjun Sha; Weiliang Xia
Journal:  Theranostics       Date:  2021-04-26       Impact factor: 11.556

3.  Notch signalling is a potential resistance mechanism of progenitor cells within patient-derived prostate cultures following ROS-inducing treatments.

Authors:  John R Packer; Adam M Hirst; Alastair P Droop; Rachel Adamson; Matthew S Simms; Vincent M Mann; Fiona M Frame; Deborah O'Connell; Norman J Maitland
Journal:  FEBS Lett       Date:  2019-09-17       Impact factor: 4.124

4.  Hypoxia regulates Notch-3 mRNA and receptor activation in prostate cancer cells.

Authors:  Armelle Meunier; Angela Nilda Flores; Niamh McDermott; Karla Rivera-Figueroa; Antoinette Perry; Thomas Lynch; Kathrine Røe Redalen; Laure Marignol
Journal:  Heliyon       Date:  2016-05-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.